The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Living Without Fear

December 17, 2010 10:34 am | Podcasts | Comments

Doctors at University of Iowa have been studying a female patient they call "SM" for more than 20 years. SM has a damaged amygdala, a part of the brain. As a result, she doesn't experience fear. Daniel Tranel explains what doctors have learned from SM and how that information might be useful.

Visions Of Energy Efficiency Danced In Their Heads

December 17, 2010 10:34 am | Podcasts | Comments

Homeowners hoping to save on utility bills may want to ask Santa for a storm door or insulation. Dec. 31 is the deadline for the energy tax credits that could cut your tax bill by up to $1,500. Science Friday runs down how to save some green this winter.

Science Diction: The Origin Of The Word 'Comet'

December 17, 2010 10:34 am | Podcasts | Comments

Although comets were sighted at least as early as 1000 B.C., Greek natural philosophers named them sometime around 500 B.C., using the Greek word kometes for "a head with long hair." Science historian Howard Markel discusses the word's origins and the study of comets through the centuries.


Who's Tracking You Online?

December 17, 2010 10:34 am | Podcasts | Comments

Many top websites deposit tracking tools on Internet surfers' computers, in order to help online marketers target ads. Ira Flatow and guests discuss Internet tracking, and the Federal Trade Commission's suggestion that browser makers build in a sort of "do not track" button.

Katz joins NeuroMetrix board

December 17, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

NeuroMetrix Inc., a Waltham-based developer of medical devices and therapies to treat neurological and spinal conditions, has appointed Nancy Katz to its board of directors.

FDA Workshop - Assuring the Safety and Effectiveness of Seizure, Cognitive Function, and TBI/Sports Concussion Diagnostic Devices, June 2-3, 2011

December 17, 2010 10:33 am | by U.S. Food & Drug Administration | News | Comments

Attendees will discuss approaches and endpoints for clinical studies for these devices and how the results should be conveyed to the users so that the devices may be used effectively.

RXi plans IND for anti-scarring treatment

December 17, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

RXi Pharmaceuticals Corp. of Worcester is preparing to bring its first RNAi product into development, with the filing of an investigational new drug (IND) application for its therapeutic candidate in reducing surgical scarring.

Accuray Establishes Medical Affairs Function

December 17, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Dec. 17, 2010 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that the company has established a Medical Affairs function to accelerate CyberKnife data collection, utilization and referral patterns and to provide...


Boston researchers test treatment for autism link

December 17, 2010 9:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Children's Hospital Boston scientists have initiated a three-year clinical trial to test a potential treatment for Rett Syndrome, known to cause autism in girls.


Anzemet (dolasetron mesylate): Drug Safety Communication - Reports of Abnormal Heart Rhythms

December 17, 2010 8:34 am | by U.S. Food & Drug Administration | News | Comments

Injection form of Anzemet (dolasetron mesylate) should no longer be used to prevent nausea and vomiting associated with cancer chemotherapy in pediatric and adult patients.

VIDEO From Siemens and Synaptic Digital: Not Your Father's X-Ray Machine

December 17, 2010 8:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 17, 2010 /- Say so-long to the days of black and white 2-D X-rays and images. From CT, to MRI and PET, medical imaging is faster, more detailed, and three-dimensional and is revolutionizing the way medicine is practiced.  Thanks to years of improved imaging, today's...


Cephalon founder, CEO Frank Baldino Jr. dies at 57

December 17, 2010 7:45 am | by The Associated Press | News | Comments

Cephalon Inc. Chairman and CEO Frank Baldino Jr. died Thursday evening, the biotechnology company said. He was 57.Chief Operating Officer J. Kevin Buchi took over Baldino's day-to-day responsibilities in August and will continue doing that, said Fritz Bittenbender, vice president for public...

An ITG Majestic Market Research Study Indicates a Bright Future for Gilenya, Despite Concerns About Its Safety

December 17, 2010 7:31 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 17, 2010 /- A study published this week by ITG (NYSE: ITG ) revealed that Novartis recently approved drug, Gilenya, has already taken share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year.  ...


System Host Board Offers Real-Time, Image Processing Applications

December 17, 2010 6:44 am | Kontron America, Inc. | Product Releases | Comments

Kontron introduces the PICMG 1.3 System Host Board Kontron PCI-761, a slot card-sized industrial server board that is equipped with the Intel Q57 Express chipset.

BG Medicine backs out of IPO

December 17, 2010 6:31 am | by Mass High Tech: The Journal of New England Technology | News | Comments

On the cusp of going public, BG Medicine Inc. has pulled its IPO, Dow Jones reports. BG, which is developing a cardiac diagnostic test, initially filed to go public in January with plans for an $86.3 million offering before scaling back twice prior to pulling the plug.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.